- Home
- PSF vs OSUR Comparison
PSF vs OSUR Comparison
Compare PSF & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSF
- OSUR
- Stock Information
- Founded
- PSF 2010
- OSUR 2000
- Country
- PSF United States
- OSUR United States
- Employees
- PSF N/A
- OSUR N/A
- Industry
- PSF Investment Managers
- OSUR Medical/Dental Instruments
- Sector
- PSF Finance
- OSUR Health Care
- Exchange
- PSF Nasdaq
- OSUR Nasdaq
- Market Cap
- PSF 242.7M
- OSUR 289.4M
- IPO Year
- PSF N/A
- OSUR 1986
- Fundamental
- Price
- PSF $19.72
- OSUR $3.79
- Analyst Decision
- PSF
- OSUR Hold
- Analyst Count
- PSF 0
- OSUR 2
- Target Price
- PSF N/A
- OSUR $5.50
- AVG Volume (30 Days)
- PSF 25.0K
- OSUR 882.2K
- Earning Date
- PSF 01-01-0001
- OSUR 11-06-2024
- Dividend Yield
- PSF 7.69%
- OSUR N/A
- EPS Growth
- PSF N/A
- OSUR N/A
- EPS
- PSF N/A
- OSUR 0.15
- Revenue
- PSF N/A
- OSUR $224,263,000.00
- Revenue This Year
- PSF N/A
- OSUR N/A
- Revenue Next Year
- PSF N/A
- OSUR N/A
- P/E Ratio
- PSF N/A
- OSUR $25.09
- Revenue Growth
- PSF N/A
- OSUR N/A
- 52 Week Low
- PSF $16.00
- OSUR $3.72
- 52 Week High
- PSF $20.19
- OSUR $8.45
- Technical
- Relative Strength Index (RSI)
- PSF 34.13
- OSUR 43.14
- Support Level
- PSF $19.81
- OSUR $3.78
- Resistance Level
- PSF $20.24
- OSUR $4.14
- Average True Range (ATR)
- PSF 0.13
- OSUR 0.18
- MACD
- PSF -0.04
- OSUR 0.00
- Stochastic Oscillator
- PSF 17.14
- OSUR 9.30
About PSF Cohen & Steers Select Preferred and Income Fund Inc.
Cohen & Steers Select Preferred and Income Fund Inc is a diversified, closed-end investment company. The Fund's primary investment objective is high current income with capital appreciation as its secondary objective. The Fund invests at least of its Managed Assets in preferred and other income securities issued by U.S. and non-U.S. companies.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.